Clinical Trial Update: HFS-guided Renal Ablation for Improving Outcome of Renal Denervation Procedure [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating HFS-guided renal ablation to improve outcomes of renal denervation for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Hypertension | Phase 2 | Status: UNKNOWN